R&D Breakthrough: Engineered Cyanobacterium Boosts Bioplastic Yield
Researchers at the University of Tuebingen have announced a significant advancement in the field of phototrophic biotechnology, revealing a newly engineered strain of cyanobacteria capable of producing industrial quantities of polyhydroxybutyrate (PHB). This development marks a critical step toward decoupling bioplastic production from agricultural feedstocks, utilizing carbon dioxide and sunlight as the primary inputs.
Rewiring Cellular Metabolism
Cyanobacteria naturally produce PHB, a member of the polyhydroxyalkanoate (PHA) family, as a nutrient storage mechanism during times of stress. However, wild-type strains typically yield quantities too low for economic competition with fossil-fuel-based plastics or sugar-fed bacterial fermentation.
The research team at the University of Tuebingen successfully modified the metabolic pathways of the cyanobacterium Synechocystis. By regulating the carbon fluxāessentially directing the organism’s energy away from general biomass growth and glycogen storageāthe team forced the bacteria to channel the majority of fixed carbon directly into PHB synthesis. The resulting strain demonstrated a massive increase in intracellular PHB content without compromising the organism’s viability.
From Lab to Industrial Application
PHB is highly valued in the bioplastics market due to its biodegradability and physical properties, which closely resemble those of polypropylene (PP). It is thermoplastic, biocompatible, and completely degrades into non-toxic byproducts in marine and soil environments.
Until now, high production costs have limited PHB to niche medical and pharmaceutical applications. The new photosynthetic approach eliminates the need for expensive organic carbon sources (like glucose or vegetable oils), potentially lowering the cost of goods sold (COGS) for PHB resins.
“This engineered strain represents a paradigm shift from carbon-neutral to carbon-negative plastic production,” the research team noted. The university is reportedly exploring partnerships with chemical engineering firms to pilot the cultivation of this strain in large-scale photobioreactors, aiming to validate the technology for commercial resin production.
Source: Read more